Provided by Tiger Trade Technology Pte. Ltd.

Co-Diagnostics, Inc.

2.33
-0.0200-0.85%
Volume:6.94K
Turnover:16.26K
Market Cap:4.73M
PE:-0.08
High:2.39
Open:2.35
Low:2.31
Close:2.35
52wk High:46.50
52wk Low:2.20
Shares:2.03M
Float Shares:1.80M
Volume Ratio:0.66
T/O Rate:0.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-29.0077
EPS(LYR):-37.2229
ROE:-62.12%
ROA:-37.92%
PB:0.12
PE(LYR):-0.06

Loading ...

Company Profile

Company Name:
Co-Diagnostics, Inc.
Exchange:
PINK LIMITED
Establishment Date:
2013
Employees:
132
Office Location:
2401 S. Foothill Dr.,Suite D,Salt Lake City,Utah,United States
Zip Code:
84109
Fax:
- -
Introduction:
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. The company offers Co-Dx PCR platform, a polymerase chain reaction (PCR) testing to patients in point-of-care and at-home setting. It also provides PCR diagnostic tests for COVID-19, influenza, tuberculosis, hepatitis B and C, human papillomavirus, malaria, chikungunya, dengue, and the zika virus. In addition, the company offers three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications; tests that identify genetic traits in plant and animal genomes; and portable diagnostic device designed to bring PCR to patients in point-of-care and at-home settings. The company was incorporated in 2013 and is headquartered in Salt Lake City, Utah.